Creatine Kinase: biomarker evidence

Creatine Kinase appears in 1 entry of the OSMF biomarker atlas, covering Epilepsy. Across those entries it is elevated in 1. It is currently reported in a single condition in this atlas; cross-condition comparison will be added as the dataset grows. Each row below links to a page with the comparison group, associated symptoms, test details and primary citation.

Epilepsy

Where Creatine Kinase is reported

ConditionDirectionCompared againstAssociated symptomsSource
Epilepsy↑ elevatedhealthy dogs—Paltrinieri et al. 2017

Frequently asked questions

In which conditions is Creatine Kinase altered?

In the OSMF atlas Creatine Kinase is reported in Epilepsy. It is elevated in 1 across 1 entries.

Is there a standard clinical test for Creatine Kinase?

The atlas entries for Creatine Kinase do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.

Is one abnormal Creatine Kinase result diagnostic?

No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.

Cite this page

Open Source Medicine Foundation. (2026). Creatine Kinase across conditions: biomarker evidence. OSMF Research Tracker. Retrieved November 21, 2026, from https://research.opensourcemed.info/biomarkers/markers/creatine-kinase.html

Last reviewed: 2026-10-08 · Browse: Biomarker Index · All marker pages · Biomarker Atlas

Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.